Hanna Wald

3.3k citations

104 papers · 2.7k indexed · h-index 31

Impact in

Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
Hematology top 2%
- Multiple Myeloma Research and Treatments

Papers in

Nephrology 24
- Parathyroid Disorders and Treatments 15
Oncology 47
- Chemokine receptors and signaling 22
- Drug Transport and Resistance Mechanisms 12

Co-authors: Amnon Peled Eithan Galun M. M. Popovtzer Katia Beider Haim Garty Michal Abraham Ori Wald Arnon Nagler
Journals: Pflügers Archiv - European Journal of Physiology (14 papers)American Journal of Physiology-Renal Physiology (13 papers)Blood (8 papers)Clinical Cancer Research (3 papers)Frontiers in Immunology (3 papers)
Partner nations: Israel United States Germany

In The Last Decade

Hanna Wald

103 papers receiving 2.6k citations

Peers

Countries citing papers authored by Hanna Wald

Since Specialization

Citations

This map shows the geographic impact of Hanna Wald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanna Wald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanna Wald more than expected).

Fields of papers citing papers by Hanna Wald

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hanna Wald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanna Wald. The network helps show where Hanna Wald may publish in the future.

Co-authors

The 25 scholars most cited alongside Hanna Wald, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hanna Wald Line = papers co-authored together Hanna Wald links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Identification of Dinaciclib and Ganetespib as anti-inflammatory drugs using a novel HTP screening assay that targets IFNγ-dependent PD-L1 Frontiers in Immunology ·Shira Hagbi-Levi, Michal Abraham, Long Ma, DWIGHT E. CURRY, Nor Dalila Farhana Osman, Arméstar Fernando, Ori Wald, Hanna Wald, Devorah Olam, Yong-Jin Chun, Amnon Peled	2025	0
2	Deep dive into the immune response against murine mesothelioma permits design of novel anti-mesothelioma therapeutics Frontiers in Immunology ·R. Harris, Stefano Caruso, Clément Meiller, Inbal Mishalian, Théo Z. Hirsch, Quentin Bayard, Carmit T. Tadmor, Hanna Wald, Didier Jean, Ori Wald	2023	2
3	CXCR4 Promotes Neuroblastoma Growth and Therapeutic Resistance through miR-15a/16-1–Mediated ERK and BCL2/Cyclin D1 Pathways Cancer Research ·Shiri Klein, Michal Abraham, Baruch Bulvik, Владимир Маркович Исаков, Ido D. Weiss, Neta Barashi, Rinat Abramovitch, Hanna Wald, Peter S Spencer, Devorah Olam, Lola Weiss, Katia Beider, Orly Eizenberg, Ori Wald, Eithan Galun, Yaron Pereg, Amnon Peled	2017	48
4	The CXCR4 inhibitor BL-8040 induces the apoptosis of AML blasts by downregulating ERK, BCL-2, MCL-1 and cyclin-D1 via altered miR-15a/16-1 expression Leukemia ·Michal Abraham, Shiri Klein, Baruch Bulvik, Hanna Wald, Ido D. Weiss, Devorah Olam, Lola Weiss, Katia Beider, Orly Eizenberg, Ori Wald, Eithan Galun, Abraham Avigdor, Ohad Benjamini, Arnon Nagler, Yaron Pereg, Sigal Tavor, Amnon Peled	2017	86
5	The Sphingosine-1-Phosphate Modulator FTY720 Targets Multiple Myeloma via the CXCR4/CXCL12 Pathway Clinical Cancer Research ·Katia Beider, Michel Picard, Plamen Tzokov, Avichai Shimoni, Merav Leiba, Maya Koren‐Michowitz, Elena Ribakovsky, Shiri Klein, Devorah Olam, Lola Weiss, Hanna Wald, Michal Abraham, Eithan Galun, Amnon Peled, Fulvio Grassi Marangione	2016	33
6	Combination of Imatinib with CXCR4 Antagonist BKT140 Overcomes the Protective Effect of Stroma and Targets CML In Vitro and In Vivo Molecular Cancer Therapeutics ·Katia Beider, Merav Darash‐Yahana, 裕介大石, Maya Koren‐Michowitz, Michal Abraham, Hanna Wald, Ori Wald, Eithan Galun, Orly Eizenberg, Amnon Peled, Arnon Nagler	2014	51
7	The High-Affinity CXCR4 Antagonist BKT140 Is Safe and Induces a Robust Mobilization of Human CD34+ Cells in Patients with Multiple Myeloma Clinical Cancer Research ·Amnon Peled, Michal Abraham, Irit Avivi, Jacob M. Rowe, Katia Beider, Hanna Wald, Ángela Natalia Ortíz Arteaga, Nathan Alexander Mehlhop, Diana Briel, A. F., Sylvie Kirsch, Eithan Galun, Luis Donizetti da Silva Stracieri, Orly Eizenberg, Izhar Hardan, Avichai Shimoni, Arnon Nagler	2013	70
8	Targeting the CD20 and CXCR4 Pathways in Non-Hodgkin Lymphoma with Rituximab and High-Affinity CXCR4 Antagonist BKT140 Clinical Cancer Research ·Katia Beider, Elena Ribakovsky, Michal Abraham, Hanna Wald, Lola Weiss, Michel Picard, Eithan Galun, Abraham Avigdor, Orly Eizenberg, Amnon Peled, Arnon Nagler	2013	48
9	Inflammation-Induced Hepatocellular Carcinoma Is Dependent on Ccr5 in Mice Hepatology ·Neta Barashi, Ido D. Weiss, Ori Wald, Hanna Wald, Katia Beider, Michal Abraham, Shiri Klein, Daniel Goldenberg, Jonathan H. Axelrod, Eli Pikarsky, Rinat Abramovitch, Evelyne Zeira, Eithan Galun, Amnon Peled	2013	59
10	In vitro and in vivo therapeutic efficacy of CXCR4 antagonist BKT140 against human non–small cell lung cancer Journal of Thoracic and Cardiovascular Surgery ·R. Bruce Harley, Ido D. Weiss, Michal Abraham, Katia Beider, Hanna Wald, Íñigo López Simón, Orly Eizenberg, Gideon Zamir, Uzi Izhar, Oz M. Shapira, Amnon Peled, Ori Wald	2012	56
11	IFN-γ Treatment at Early Stages of Influenza Virus Infection Protects Mice from Death in a NK Cell-Dependent Manner Journal of Interferon & Cytokine Research ·Ido D. Weiss, Ori Wald, Hanna Wald, Katia Beider, Michal Abraham, Eithan Galun, Arnon Nagler, Amnon Peled	2010	80
12	The CXCR4 antagonist 4F-benzoyl-TN14003 stimulates the recovery of the bone marrow after transplantation Leukemia ·Michal Abraham, Katia Beider, Hanna Wald, Ido D. Weiss, Dov Zipori, Eithan Galun, A. Nagler, Orly Eizenberg, Amnon Peled	2009	33
13	IFN-γ Acts on T Cells to Induce NK Cell Mobilization and Accumulation in Target Organs The Journal of Immunology ·Ori Wald, Ido D. Weiss, Hanna Wald, Hadas Shoham, 斎藤寿彦, Katia Beider, Eithan Galun, Lola Weiss, Liat Flaishon, Idit Shachar, Arnon Nagler, Bao Lu, Craig Gérard, Ji‐Liang Gao, Eyal Mishani, Joshua Μ. Farber, Amnon Peled	2006	77
14	Late-onset downregulation of NaPi-2 in experimental Fanconi syndrome Pediatric Nephrology ·Yosef S. Haviv, Hanna Wald, Moshe Levi, 眞紀夫石澤, M. M. Popovtzer	2001	2
15	Glycerol-Induced Acute Renal Failure Attenuates Subsequent HgCl ₂ -Associated Nephrotoxicity: Correlation of Renal Function and Morphology Renal Failure ·Rebecca Backenroth, K B Sprenger, Hanna Wald, Mordecai M. Popovtzer	1998	10
16	Role of down-regulated CHIF mRNA in the pathophysiology of hyperkalemia of acute tubular necrosis American Journal of Kidney Diseases ·砥石石, Hanna Wald, M. M. Popovtzer	1998	8
17	Evidence for interference of vitamin D with PTH/PTHrP receptor expression in opossum kidney cells Pflügers Archiv - European Journal of Physiology ·Hanna Wald, 眞紀夫石澤, Rebecca Backenroth, Mordecai M. Popovtzer	1998	2
18	Effect of myo-inositol supplementation on the development of renal pathological changes in the Cohen diabetic (type 2) rat Diabetologia ·A. M. Cohen, Hanna Wald, M. M. Popovtzer, E. Rosenmann	1995	14
19	22-Oxacalcitriol does not interfere with parathyroid hormone-induced phosphaturia or cyclic-AMP excretion Bone ·Michael M. Friedlaender, Yoram Yagil, Hanna Wald, Benjamin J. Zechmann	1995	5
20	Renal sodium handling and stimulation of medullary NaKATPase during blockade of prostaglandin synthesis Prostaglandins ·Dvora Rubinger, Hanna Wald, Peter Scherzer, M. M. Popovtzer	1990	9

About Hanna Wald

Hanna Wald is a scholar working on Nephrology, Oncology, Hematology, Immunology and Pathology and Forensic Medicine, having authored 104 papers that have together received 2.7k indexed citations. Recurring topics across this work include Ion Transport and Channel Regulation (37 papers), Chemokine receptors and signaling (22 papers), Immunotherapy and Immune Responses (17 papers), Parathyroid Disorders and Treatments (15 papers), Electrolyte and hormonal disorders (12 papers), Drug Transport and Resistance Mechanisms (12 papers), Vitamin D Research Studies (10 papers) and Immune Cell Function and Interaction (10 papers). The work is most often cited by research in Immunology (882 citations), Hematology (379 citations), Nephrology (235 citations), Oncology (853 citations) and Hepatology (139 citations). Hanna Wald has collaborated with scholars based in Israel, United States and Germany. Frequent co-authors include Amnon Peled, Eithan Galun, M. M. Popovtzer, Katia Beider, Haim Garty, Michal Abraham, Ori Wald, Arnon Nagler, Ido D. Weiss and Carol Asher. Their work appears in journals such as Pflügers Archiv - European Journal of Physiology, American Journal of Physiology-Renal Physiology, Blood, Clinical Cancer Research and Frontiers in Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact